⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DYN News
Dyne Therapeutics, Inc. Common Stock
The Authority Images and Vaults Over 10 million Collectibles in Less Than Six Months After Launch
prnewswire.com
DYN
Form 8-K
sec.gov
DYN
Form 8-K
sec.gov
DYN
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
globenewswire.com
DYN
Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
globenewswire.com
DYN
It’s Time to Set Things Right at Dynacor and Ensure the Viability and Success of the Company
businesswire.com
DYN
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DYN
Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval
globenewswire.com
DYN
Dyne Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
DYN
Form 8-K
sec.gov
DYN